Index by author
July 01, 1995; Volume 23,Issue 7
A
Acheampong, A A
- You have accessComparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits.A A Acheampong, M Shackleton and D D Tang-LiuDrug Metabolism and Disposition July 1995, 23 (7) 708-712;
Agen, C
- You have accessPlasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice.F Innocenti, R Danesi, A Di Paolo, C Agen, D Nardini, G Bocci and M Del TaccaDrug Metabolism and Disposition July 1995, 23 (7) 713-717;
B
Balani, S K
- You have accessSpecies differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.T Prueksaritanont, S K Balani, L M Dwyer, J D Ellis, L R Kauffman, S L Varga, S M Pitzenberger and A D TheoharidesDrug Metabolism and Disposition July 1995, 23 (7) 688-695;
Bocci, G
- You have accessPlasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice.F Innocenti, R Danesi, A Di Paolo, C Agen, D Nardini, G Bocci and M Del TaccaDrug Metabolism and Disposition July 1995, 23 (7) 713-717;
Born, S L
- You have accessCharacterization of the progesterone 21-hydroxylase activity of canine cytochrome P450 PBD-2/P450 2B11 through reconstitution, heterologous expression, and site-directed mutagenesis.S L Born, G H John, G R Harlow and J R HalpertDrug Metabolism and Disposition July 1995, 23 (7) 702-707;
Bowers, G D
- You have accessMicrobial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.R J Cannell, A R Knaggs, M J Dawson, G R Manchee, P J Eddershaw, I Waterhouse, D R Sutherland, G D Bowers and P J SidebottomDrug Metabolism and Disposition July 1995, 23 (7) 724-729;
Bracken, W
- You have accessInduction of liver microsomal cytochrome P450 in cynomolgus monkeys.P Bullock, R Pearce, A Draper, J Podval, W Bracken, J Veltman, P Thomas and A ParkinsonDrug Metabolism and Disposition July 1995, 23 (7) 736-748;
Bullock, P
- You have accessInduction of liver microsomal cytochrome P450 in cynomolgus monkeys.P Bullock, R Pearce, A Draper, J Podval, W Bracken, J Veltman, P Thomas and A ParkinsonDrug Metabolism and Disposition July 1995, 23 (7) 736-748;
Buters, J T
- You have accesscDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification.J T Buters, M Shou, J P Hardwick, K R Korzekwa and F J GonzalezDrug Metabolism and Disposition July 1995, 23 (7) 696-701;
C
Cannell, R J
- You have accessMicrobial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.R J Cannell, A R Knaggs, M J Dawson, G R Manchee, P J Eddershaw, I Waterhouse, D R Sutherland, G D Bowers and P J SidebottomDrug Metabolism and Disposition July 1995, 23 (7) 724-729;
Carlson, T J
- You have accessStereoselectivity and isotope effects associated with cytochrome P450-catalyzed oxidation of (S)-nicotine. The possibility of initial hydrogen atom abstraction in the formation of the delta 1', 5-nicotinium ion.T J Carlson, J P Jones, L Peterson, N Castagnoli, K R Iyer and W F TragerDrug Metabolism and Disposition July 1995, 23 (7) 749-756;
Carrel, B K
- You have accessDisposition and cardioselectivity of MDL 74,405, a vitamin E-like free radical scavenger, in rats and dogs after intravenous infusion.B S Kuo, B S Mathews, J D Stuhler, B K Carrel, J Ho and J Q RoseDrug Metabolism and Disposition July 1995, 23 (7) 757-764;
Castagnoli, N
- You have accessStereoselectivity and isotope effects associated with cytochrome P450-catalyzed oxidation of (S)-nicotine. The possibility of initial hydrogen atom abstraction in the formation of the delta 1', 5-nicotinium ion.T J Carlson, J P Jones, L Peterson, N Castagnoli, K R Iyer and W F TragerDrug Metabolism and Disposition July 1995, 23 (7) 749-756;
Chen, I W
- You have accesspH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs.J H Lin, I W Chen, K J Vastag and D OstovicDrug Metabolism and Disposition July 1995, 23 (7) 730-735;
Cribb, A
- You have accessAntipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6.A Cribb, C Nuss and R WangDrug Metabolism and Disposition July 1995, 23 (7) 671-675;
D
Danesi, R
- You have accessPlasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice.F Innocenti, R Danesi, A Di Paolo, C Agen, D Nardini, G Bocci and M Del TaccaDrug Metabolism and Disposition July 1995, 23 (7) 713-717;
Dawson, M J
- You have accessMicrobial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.R J Cannell, A R Knaggs, M J Dawson, G R Manchee, P J Eddershaw, I Waterhouse, D R Sutherland, G D Bowers and P J SidebottomDrug Metabolism and Disposition July 1995, 23 (7) 724-729;
Del Tacca, M
- You have accessPlasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice.F Innocenti, R Danesi, A Di Paolo, C Agen, D Nardini, G Bocci and M Del TaccaDrug Metabolism and Disposition July 1995, 23 (7) 713-717;
Di Paolo, A
- You have accessPlasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice.F Innocenti, R Danesi, A Di Paolo, C Agen, D Nardini, G Bocci and M Del TaccaDrug Metabolism and Disposition July 1995, 23 (7) 713-717;
Draper, A
- You have accessInduction of liver microsomal cytochrome P450 in cynomolgus monkeys.P Bullock, R Pearce, A Draper, J Podval, W Bracken, J Veltman, P Thomas and A ParkinsonDrug Metabolism and Disposition July 1995, 23 (7) 736-748;
Dwyer, L M
- You have accessSpecies differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.T Prueksaritanont, S K Balani, L M Dwyer, J D Ellis, L R Kauffman, S L Varga, S M Pitzenberger and A D TheoharidesDrug Metabolism and Disposition July 1995, 23 (7) 688-695;
E
Eddershaw, P J
- You have accessMicrobial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.R J Cannell, A R Knaggs, M J Dawson, G R Manchee, P J Eddershaw, I Waterhouse, D R Sutherland, G D Bowers and P J SidebottomDrug Metabolism and Disposition July 1995, 23 (7) 724-729;
Elder, C A
- You have accessInterspecies scaling of a thienodiazepine platelet-activating factor receptor antagonist.C A Elder and M W ModiDrug Metabolism and Disposition July 1995, 23 (7) 776-778;
Ellis, J D
- You have accessSpecies differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.T Prueksaritanont, S K Balani, L M Dwyer, J D Ellis, L R Kauffman, S L Varga, S M Pitzenberger and A D TheoharidesDrug Metabolism and Disposition July 1995, 23 (7) 688-695;
Estabrook, R W
- You have accessIn vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.A D Rodrigues, D J Mulford, R D Lee, B W Surber, M J Kukulka, J L Ferrero, S B Thomas, M S Shet and R W EstabrookDrug Metabolism and Disposition July 1995, 23 (7) 765-775;
F
Ferrero, J L
- You have accessIn vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.A D Rodrigues, D J Mulford, R D Lee, B W Surber, M J Kukulka, J L Ferrero, S B Thomas, M S Shet and R W EstabrookDrug Metabolism and Disposition July 1995, 23 (7) 765-775;
G
Gonzalez, F J
- You have accesscDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification.J T Buters, M Shou, J P Hardwick, K R Korzekwa and F J GonzalezDrug Metabolism and Disposition July 1995, 23 (7) 696-701;
H
Halpert, J R
- You have accessCharacterization of the progesterone 21-hydroxylase activity of canine cytochrome P450 PBD-2/P450 2B11 through reconstitution, heterologous expression, and site-directed mutagenesis.S L Born, G H John, G R Harlow and J R HalpertDrug Metabolism and Disposition July 1995, 23 (7) 702-707;
Hardwick, J P
- You have accesscDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification.J T Buters, M Shou, J P Hardwick, K R Korzekwa and F J GonzalezDrug Metabolism and Disposition July 1995, 23 (7) 696-701;
Harlow, G R
- You have accessCharacterization of the progesterone 21-hydroxylase activity of canine cytochrome P450 PBD-2/P450 2B11 through reconstitution, heterologous expression, and site-directed mutagenesis.S L Born, G H John, G R Harlow and J R HalpertDrug Metabolism and Disposition July 1995, 23 (7) 702-707;
Ho, J
- You have accessDisposition and cardioselectivity of MDL 74,405, a vitamin E-like free radical scavenger, in rats and dogs after intravenous infusion.B S Kuo, B S Mathews, J D Stuhler, B K Carrel, J Ho and J Q RoseDrug Metabolism and Disposition July 1995, 23 (7) 757-764;
I
Iga, T
- You have accessComparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.M Katashima, K Yamamoto, M Sugiura, Y Sawada and T IgaDrug Metabolism and Disposition July 1995, 23 (7) 718-723;
Innocenti, F
- You have accessPlasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice.F Innocenti, R Danesi, A Di Paolo, C Agen, D Nardini, G Bocci and M Del TaccaDrug Metabolism and Disposition July 1995, 23 (7) 713-717;
Iyer, K R
- You have accessStereoselectivity and isotope effects associated with cytochrome P450-catalyzed oxidation of (S)-nicotine. The possibility of initial hydrogen atom abstraction in the formation of the delta 1', 5-nicotinium ion.T J Carlson, J P Jones, L Peterson, N Castagnoli, K R Iyer and W F TragerDrug Metabolism and Disposition July 1995, 23 (7) 749-756;
J
John, G H
- You have accessCharacterization of the progesterone 21-hydroxylase activity of canine cytochrome P450 PBD-2/P450 2B11 through reconstitution, heterologous expression, and site-directed mutagenesis.S L Born, G H John, G R Harlow and J R HalpertDrug Metabolism and Disposition July 1995, 23 (7) 702-707;
Jones, J P
- You have accessStereoselectivity and isotope effects associated with cytochrome P450-catalyzed oxidation of (S)-nicotine. The possibility of initial hydrogen atom abstraction in the formation of the delta 1', 5-nicotinium ion.T J Carlson, J P Jones, L Peterson, N Castagnoli, K R Iyer and W F TragerDrug Metabolism and Disposition July 1995, 23 (7) 749-756;
K
Katashima, M
- You have accessComparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.M Katashima, K Yamamoto, M Sugiura, Y Sawada and T IgaDrug Metabolism and Disposition July 1995, 23 (7) 718-723;
Kauffman, L R
- You have accessSpecies differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.T Prueksaritanont, S K Balani, L M Dwyer, J D Ellis, L R Kauffman, S L Varga, S M Pitzenberger and A D TheoharidesDrug Metabolism and Disposition July 1995, 23 (7) 688-695;
Knaggs, A R
- You have accessMicrobial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.R J Cannell, A R Knaggs, M J Dawson, G R Manchee, P J Eddershaw, I Waterhouse, D R Sutherland, G D Bowers and P J SidebottomDrug Metabolism and Disposition July 1995, 23 (7) 724-729;
Kocarek, T A
- You have accessXenobiotic-enhanced expression of cytochrome P450 2E1 and 2B1/2B2 in primary cultured rat hepatocytes.R C Zangar, K J Woodcroft, T A Kocarek and R F NovakDrug Metabolism and Disposition July 1995, 23 (7) 681-687;
Korzekwa, K R
- You have accesscDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification.J T Buters, M Shou, J P Hardwick, K R Korzekwa and F J GonzalezDrug Metabolism and Disposition July 1995, 23 (7) 696-701;
Kukulka, M J
- You have accessIn vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.A D Rodrigues, D J Mulford, R D Lee, B W Surber, M J Kukulka, J L Ferrero, S B Thomas, M S Shet and R W EstabrookDrug Metabolism and Disposition July 1995, 23 (7) 765-775;
Kuo, B S
- You have accessDisposition and cardioselectivity of MDL 74,405, a vitamin E-like free radical scavenger, in rats and dogs after intravenous infusion.B S Kuo, B S Mathews, J D Stuhler, B K Carrel, J Ho and J Q RoseDrug Metabolism and Disposition July 1995, 23 (7) 757-764;
L
Lee, R D
- You have accessIn vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.A D Rodrigues, D J Mulford, R D Lee, B W Surber, M J Kukulka, J L Ferrero, S B Thomas, M S Shet and R W EstabrookDrug Metabolism and Disposition July 1995, 23 (7) 765-775;
Lin, J H
- You have accesspH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs.J H Lin, I W Chen, K J Vastag and D OstovicDrug Metabolism and Disposition July 1995, 23 (7) 730-735;
M
Malspeis, L
- You have accessPharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog.L R Phillips, L Malspeis and J G SupkoDrug Metabolism and Disposition July 1995, 23 (7) 676-680;
Manchee, G R
- You have accessMicrobial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.R J Cannell, A R Knaggs, M J Dawson, G R Manchee, P J Eddershaw, I Waterhouse, D R Sutherland, G D Bowers and P J SidebottomDrug Metabolism and Disposition July 1995, 23 (7) 724-729;
Mathews, B S
- You have accessDisposition and cardioselectivity of MDL 74,405, a vitamin E-like free radical scavenger, in rats and dogs after intravenous infusion.B S Kuo, B S Mathews, J D Stuhler, B K Carrel, J Ho and J Q RoseDrug Metabolism and Disposition July 1995, 23 (7) 757-764;
Modi, M W
- You have accessInterspecies scaling of a thienodiazepine platelet-activating factor receptor antagonist.C A Elder and M W ModiDrug Metabolism and Disposition July 1995, 23 (7) 776-778;
Mulford, D J
- You have accessIn vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.A D Rodrigues, D J Mulford, R D Lee, B W Surber, M J Kukulka, J L Ferrero, S B Thomas, M S Shet and R W EstabrookDrug Metabolism and Disposition July 1995, 23 (7) 765-775;
N
Nardini, D
- You have accessPlasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice.F Innocenti, R Danesi, A Di Paolo, C Agen, D Nardini, G Bocci and M Del TaccaDrug Metabolism and Disposition July 1995, 23 (7) 713-717;
Novak, R F
- You have accessXenobiotic-enhanced expression of cytochrome P450 2E1 and 2B1/2B2 in primary cultured rat hepatocytes.R C Zangar, K J Woodcroft, T A Kocarek and R F NovakDrug Metabolism and Disposition July 1995, 23 (7) 681-687;
Nuss, C
- You have accessAntipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6.A Cribb, C Nuss and R WangDrug Metabolism and Disposition July 1995, 23 (7) 671-675;
O
Ostovic, D
- You have accesspH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs.J H Lin, I W Chen, K J Vastag and D OstovicDrug Metabolism and Disposition July 1995, 23 (7) 730-735;
P
Parkinson, A
- You have accessInduction of liver microsomal cytochrome P450 in cynomolgus monkeys.P Bullock, R Pearce, A Draper, J Podval, W Bracken, J Veltman, P Thomas and A ParkinsonDrug Metabolism and Disposition July 1995, 23 (7) 736-748;
Pearce, R
- You have accessInduction of liver microsomal cytochrome P450 in cynomolgus monkeys.P Bullock, R Pearce, A Draper, J Podval, W Bracken, J Veltman, P Thomas and A ParkinsonDrug Metabolism and Disposition July 1995, 23 (7) 736-748;
Peterson, L
- You have accessStereoselectivity and isotope effects associated with cytochrome P450-catalyzed oxidation of (S)-nicotine. The possibility of initial hydrogen atom abstraction in the formation of the delta 1', 5-nicotinium ion.T J Carlson, J P Jones, L Peterson, N Castagnoli, K R Iyer and W F TragerDrug Metabolism and Disposition July 1995, 23 (7) 749-756;
Phillips, L R
- You have accessPharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog.L R Phillips, L Malspeis and J G SupkoDrug Metabolism and Disposition July 1995, 23 (7) 676-680;
Pitzenberger, S M
- You have accessSpecies differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.T Prueksaritanont, S K Balani, L M Dwyer, J D Ellis, L R Kauffman, S L Varga, S M Pitzenberger and A D TheoharidesDrug Metabolism and Disposition July 1995, 23 (7) 688-695;
Podval, J
- You have accessInduction of liver microsomal cytochrome P450 in cynomolgus monkeys.P Bullock, R Pearce, A Draper, J Podval, W Bracken, J Veltman, P Thomas and A ParkinsonDrug Metabolism and Disposition July 1995, 23 (7) 736-748;
Prueksaritanont, T
- You have accessSpecies differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.T Prueksaritanont, S K Balani, L M Dwyer, J D Ellis, L R Kauffman, S L Varga, S M Pitzenberger and A D TheoharidesDrug Metabolism and Disposition July 1995, 23 (7) 688-695;
R
Rodrigues, A D
- You have accessIn vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.A D Rodrigues, D J Mulford, R D Lee, B W Surber, M J Kukulka, J L Ferrero, S B Thomas, M S Shet and R W EstabrookDrug Metabolism and Disposition July 1995, 23 (7) 765-775;
Rose, J Q
- You have accessDisposition and cardioselectivity of MDL 74,405, a vitamin E-like free radical scavenger, in rats and dogs after intravenous infusion.B S Kuo, B S Mathews, J D Stuhler, B K Carrel, J Ho and J Q RoseDrug Metabolism and Disposition July 1995, 23 (7) 757-764;
S
Sawada, Y
- You have accessComparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.M Katashima, K Yamamoto, M Sugiura, Y Sawada and T IgaDrug Metabolism and Disposition July 1995, 23 (7) 718-723;
Shackleton, M
- You have accessComparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits.A A Acheampong, M Shackleton and D D Tang-LiuDrug Metabolism and Disposition July 1995, 23 (7) 708-712;
Shet, M S
- You have accessIn vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.A D Rodrigues, D J Mulford, R D Lee, B W Surber, M J Kukulka, J L Ferrero, S B Thomas, M S Shet and R W EstabrookDrug Metabolism and Disposition July 1995, 23 (7) 765-775;
Shou, M
- You have accesscDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification.J T Buters, M Shou, J P Hardwick, K R Korzekwa and F J GonzalezDrug Metabolism and Disposition July 1995, 23 (7) 696-701;
Sidebottom, P J
- You have accessMicrobial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.R J Cannell, A R Knaggs, M J Dawson, G R Manchee, P J Eddershaw, I Waterhouse, D R Sutherland, G D Bowers and P J SidebottomDrug Metabolism and Disposition July 1995, 23 (7) 724-729;
Stuhler, J D
- You have accessDisposition and cardioselectivity of MDL 74,405, a vitamin E-like free radical scavenger, in rats and dogs after intravenous infusion.B S Kuo, B S Mathews, J D Stuhler, B K Carrel, J Ho and J Q RoseDrug Metabolism and Disposition July 1995, 23 (7) 757-764;
Sugiura, M
- You have accessComparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.M Katashima, K Yamamoto, M Sugiura, Y Sawada and T IgaDrug Metabolism and Disposition July 1995, 23 (7) 718-723;
Supko, J G
- You have accessPharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog.L R Phillips, L Malspeis and J G SupkoDrug Metabolism and Disposition July 1995, 23 (7) 676-680;
Surber, B W
- You have accessIn vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.A D Rodrigues, D J Mulford, R D Lee, B W Surber, M J Kukulka, J L Ferrero, S B Thomas, M S Shet and R W EstabrookDrug Metabolism and Disposition July 1995, 23 (7) 765-775;
Sutherland, D R
- You have accessMicrobial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.R J Cannell, A R Knaggs, M J Dawson, G R Manchee, P J Eddershaw, I Waterhouse, D R Sutherland, G D Bowers and P J SidebottomDrug Metabolism and Disposition July 1995, 23 (7) 724-729;
T
Tang-Liu, D D
- You have accessComparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits.A A Acheampong, M Shackleton and D D Tang-LiuDrug Metabolism and Disposition July 1995, 23 (7) 708-712;
Theoharides, A D
- You have accessSpecies differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.T Prueksaritanont, S K Balani, L M Dwyer, J D Ellis, L R Kauffman, S L Varga, S M Pitzenberger and A D TheoharidesDrug Metabolism and Disposition July 1995, 23 (7) 688-695;
Thomas, P
- You have accessInduction of liver microsomal cytochrome P450 in cynomolgus monkeys.P Bullock, R Pearce, A Draper, J Podval, W Bracken, J Veltman, P Thomas and A ParkinsonDrug Metabolism and Disposition July 1995, 23 (7) 736-748;
Thomas, S B
- You have accessIn vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.A D Rodrigues, D J Mulford, R D Lee, B W Surber, M J Kukulka, J L Ferrero, S B Thomas, M S Shet and R W EstabrookDrug Metabolism and Disposition July 1995, 23 (7) 765-775;
Trager, W F
- You have accessStereoselectivity and isotope effects associated with cytochrome P450-catalyzed oxidation of (S)-nicotine. The possibility of initial hydrogen atom abstraction in the formation of the delta 1', 5-nicotinium ion.T J Carlson, J P Jones, L Peterson, N Castagnoli, K R Iyer and W F TragerDrug Metabolism and Disposition July 1995, 23 (7) 749-756;
V
Varga, S L
- You have accessSpecies differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.T Prueksaritanont, S K Balani, L M Dwyer, J D Ellis, L R Kauffman, S L Varga, S M Pitzenberger and A D TheoharidesDrug Metabolism and Disposition July 1995, 23 (7) 688-695;
Vastag, K J
- You have accesspH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs.J H Lin, I W Chen, K J Vastag and D OstovicDrug Metabolism and Disposition July 1995, 23 (7) 730-735;
Veltman, J
- You have accessInduction of liver microsomal cytochrome P450 in cynomolgus monkeys.P Bullock, R Pearce, A Draper, J Podval, W Bracken, J Veltman, P Thomas and A ParkinsonDrug Metabolism and Disposition July 1995, 23 (7) 736-748;
W
Wang, R
- You have accessAntipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6.A Cribb, C Nuss and R WangDrug Metabolism and Disposition July 1995, 23 (7) 671-675;
Waterhouse, I
- You have accessMicrobial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.R J Cannell, A R Knaggs, M J Dawson, G R Manchee, P J Eddershaw, I Waterhouse, D R Sutherland, G D Bowers and P J SidebottomDrug Metabolism and Disposition July 1995, 23 (7) 724-729;
Woodcroft, K J
- You have accessXenobiotic-enhanced expression of cytochrome P450 2E1 and 2B1/2B2 in primary cultured rat hepatocytes.R C Zangar, K J Woodcroft, T A Kocarek and R F NovakDrug Metabolism and Disposition July 1995, 23 (7) 681-687;
Y
Yamamoto, K
- You have accessComparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.M Katashima, K Yamamoto, M Sugiura, Y Sawada and T IgaDrug Metabolism and Disposition July 1995, 23 (7) 718-723;
Z
Zangar, R C
- You have accessXenobiotic-enhanced expression of cytochrome P450 2E1 and 2B1/2B2 in primary cultured rat hepatocytes.R C Zangar, K J Woodcroft, T A Kocarek and R F NovakDrug Metabolism and Disposition July 1995, 23 (7) 681-687;
In this issue

Advertisement